1968至2018年角质形成细胞癌医疗责任索赔的州与联邦诉讼特征
该研究回顾性分析1968至2018年州与联邦上诉法院角质形成细胞癌(KC)医疗责任诉讼案件,共纳入83例。75%案件被告胜诉,近年被告胜诉比例更高;女性原告和鳞状细胞癌案件更易胜诉。
要点
- KC医疗诉讼中75%案件被告胜诉,近年被告胜诉率更高。
- 女性原告及鳞状细胞癌案件更易获得原告胜诉。
- 常见诉讼原因为未诊断、误诊和治疗延迟。
核心结论
- KC医疗责任诉讼中多数案件被告胜诉,但女性原告和SCC案件更易原告胜诉。
研究设计与样本
- 回顾性综述,检索LexisNexis Academic数据库1968年1月1日至2018年12月31日州与联邦上诉医疗责任案件,纳入83例(BCC 34例,SCC 49例)。
关键数值与推荐
- 最常见诉讼原因:未诊断18例(22%)、误诊18例(22%)、治疗延迟11例(13%)。
- 病变部位:面部/头/颈39例(47%),生殖器22例(27%),四肢15例(18%)。
- 被告专科:皮肤科19例(23%),家庭医学15例(18%),肿瘤科8例(10%)。
- 州级案件49例(59%),私营执业45例(54%)。
临床怎么用
- 提示需关注KC诊断准确性、及时治疗及特定部位(面部、生殖器)病变以降低诉讼风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The prevalence of keratinocyte carcinoma (KC) exceeds that of all other malignant neoplasms combined. Despite the steady rise of payments for medical malpractice liability claims over time, data regarding the characteristics of malpractice litigation for KC are scarce. OBJECTIVE: To identify state and federal appellate medical malpractice liability cases for KC and determine the factors associated with the verdicts. DESIGN, SETTING, AND PARTICIPANTS: This retrospective review of KC-related malpractice litigation under state or federal jurisdiction reviewed the LexisNexis Academic database of state and federal cases, legal reviews, and case law. All appellate medical malpractice cases at the state and federal levels involving basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) from January 1, 1968, through December 31, 2018, were identified. MAIN OUTCOMES AND MEASURES: Demographic characteristics of the cases and plaintiffs, verdict, health care specialty of the defendant, setting of the litigation, rationale for the lawsuit and verdict, factors associated with the case outcome, and monetary payout in cases won by the plaintiff. RESULTS: In total, 83 cases were included in our analysis (34 BCC cases and 49 SCC cases; 47 [57%] male plaintiffs). Sixty-two cases (75%) were decided in favor of the defendant. More KC-related malpractice cases were won by defendants in more recent years than were won by plaintiffs (mean year, 2004 [SD, 11 years] vs 1998 [SD, 14 years]; P = .03). Twenty-five cases (30%) each occurred in the Northeast and the South, and 45 (54%) involved private practices. Most cases involved KCs occurring on the face, head, and/or neck (39 [47%]), the genitalia (22 [27%]), or the extremities (15 [18%]). More than half of defendants were dermatologists (19 [23%]), family medicine physicians (15 [18%]), or oncologists (8 [10%]). Jurisprudence for KC-related malpractice cases most often occurred at the state level (49 [59%]). The most common causes of litigation were failure to diagnose (18 [22%]), misdiagnosis (18 [22%]), and delay in treatment (11 [13%]). More female than male plaintiffs won their malpractice cases (11 of 35 [31%] vs 5 of 43 [12%]; P = .03). More cases involving SCC than BCC led to a decision favoring the plaintiff (13 of 47 [28%] vs 3 of 31 [10%]; P = .05). In cases won by the plaintiff, the median monetary payout was $179 654 and the mean payout was $909 801 (range, $11 537-$5 320 161). CONCLUSIONS AND RELEVANCE: This study sheds light on the characteristics and settings of KC malpractice litigation claims, which is vital information for discovering potential areas of quality improvement, patient safety initiatives, and education for patients and health care professionals.
引用
- Tripathi R, Ezaldein HH, Rajkumar K, et al. Characteristics of State and Federal Malpractice Litigation of Medical Liability Claims for Keratinocyte Carcinoma, 1968 to 2018. JAMA Dermatol. 2019. PMID: 31090874. doi:10.1001/jamadermatol.2019.0430
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。